Assessment of the population demand for high-cost medical interventions: are there any reliable criteria?
Abstract
The paper discussed the causes of the substantial geographical discrepancies in the rates of cardiosurgery interventions, based on the secondary analysis of international data. The impact of these differences on mortality levels is assessed. The methods for population demand assessment are reviewed, with the focus on the intervention rates across the countries and the “number needed to treat” parameter.
About the Author
I. V. Samorodskaya
A.N. Bakoulev Research Centre for Cardiovascular Surgery. Moscow
Russian Federation
Russian Federation
References
1. Заключение о результатах проверки Счетной палаты по теме “Доступность и качество медицинской помощи населению Красноярского края как критерий эффективности использования финансовых ресурсов, направленных на здравоохранение”. http://www.ach-fci.ru/Krasnoyarsk/ activity/control/art2
2. Иванов А.В. Тихомиров А.В. Перспективы наноэкономики в развитии здравоохранения. Главный врач: хозяйство и право 2006; 6: 10-6.
3. Стародубов В.И. Национальный проект “Здоровье” дает нам шанс вывести уровень оказания медицинской помощи на новые параметры. Менед здравоохр 2006; 10: 4-11.
4. Alter DA, Austin PC, Tu JV. Canadian Cardiovascular Outcomes Research Team. Community factors, hospital characteristics and inter-regional outcome variations following acute myocardial infarction in Canada. Can J Cardiol 2005; 21: 247-55.
5. Batchelor WB, Peterson ED, Mark DB, A Comparison of U.S. and CanadianCardiac Catheterization Practices inDetecting Severe Coronary ArteryDisease After Myocardial Infarction: Efficiency, Yield and Long-Term Implications. JACC 1999; 34: 12-9.
6. Camm1 J, Klein H, Nisam S. The cost of implantable defibrillators: perceptions and reality. Eur Heart J 2007; 28(4): 392-7.
7. Cardiovascular Diseases in Europe: European Registries of Cardiovascular Diseases and Patient Management. Sophia Antipolis, France: Eur Society Cardiol 2004; р56.
8. Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD002945. DOI: 10.1002/14651858.CD002945.pub2.
9. Denvir MA, Pell JP, Lee, AJ, et al. Variations in clinical decisionmaking between cardiologists and cardiac surgeons; a case for management by multidisciplinary teams? J Cardiothorac Surg 2006; 1: 2-5.
10. Edmond JJ, French JK, Aylward PEG, et al. Variations in the Use of Emergency PCI for the Treatment of Re-infarction Following Intravenous Fibrinolytic Therapy: Impact on Outcomes in HERO-2. Eur Heart J 2007; 28(12): 1418-24.
11. Epstein AM, Weissman JS, Schneider EC, et al. Race and Gender Disparities in Rates of Cardiac Revascularization: Do They Reflect Appropriate Use of Procedures or Problems in Quality of Care? Medical Care 2003; 41(11): 1240-55.
12. Graham MM, Ghali WA, Faris PD, et al. APPROACH Investigators. Population rates of cardiaccatheterization and yield of high-risk coronary artery disease. CMAJ 2005; 173(1): 35-9.
13. Health Statistics in the Nordic Countries 2006. NOMESCO, Copenhagen 2008, 284.
14. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.
15. Leape LL, Weissman JS, Schneider EC, et al. Adherence to Practice Guidelines: The Role of Specialty Society Guidelines. Am Heart J 2003; 145(1): 19-26.
16. Majumdar SR, McAlister FA, Furberg CtD. From Knowledge to Practice in Chronic Cardiovascular Disease: A Long and Winding Road. JACC 2004; 43(10): 1738-42.
17. Martin RM, Hemingway H, Gunnell D, et al. Population need for coronary revascularisation: are national targets for England credible? Heart 2002; 88: 627-33.
18. McGovern PG, Herlitz J, Pankow JS, et al. Comparison of medical care and one- and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Goteborg, Sweden. Am J Cardiol 1997; 80: 557-62.
19. Natarajan MK, Gafni A, Yusuf S. Determining optimal population rates of cardiac catheterization: A phantom alternative? CMAJ 2005; 173(1).
20. Pell JP, Denvir MA. Angioplasty, bypass surgery or medical treatment: how should we decide? Heart 2002; 88: 451-2.
21. Ritchie JL, Wolk MJ, Hirshfeld JW, et al. Appropriate Clinical Care and Issues of “Self-Referral”. JACC 2004; 44(8): 1740-6.
22. Saia F, Lemos PA, Degertekin M, et al. Sirolimus-eluting stents for treatment of in-stent restenosis in the real world: Preliminary results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. JACC 2003; 41(Suppl II): 53A. Abstract 839FO-4.
23. Wayne HH. Do You Really Need Bypass Surgery? A Second Opinion (Hardcover-2006). http://www.heartprotect.com/ mortality-stats.shtml
Review
For citations:
Samorodskaya I.V. Assessment of the population demand for high-cost medical interventions: are there any reliable criteria? Cardiovascular Therapy and Prevention. 2010;9(8):81-85. (In Russ.)
Views:
505
Email this article 
